Nagane, M., Kobayashi, K., Kajikawa, R., Arakawa, Y., Kijima, N., Yamaguchi, S., Okita, Y., Shimoda, Y., Takami, H., Sonoda, Y., Mishima, K., Shibahara, I., Beppu, T., Nishikawa, R., Yamasaki, F., Ichimura, K., Komori, T., Sasaki, K., Fukuda, H., Narita, Y. (2025). A multicenter randomized phase III study for recurrent glioblastoma comparing bevacizumab alone with dose-dense temozolomide followed by bevacizumab: JCOG1308C.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.2046